Dr. Randall A. Oyer, founding executive medical director of the 11-year-old Ann B. Barshinger Cancer Institute, is retiring.

The European Society for Medical Oncology (ESMO) recognized Ann Partridge, MD, MPH, of Dana-Farber Cancer Institute, as a ...

ANN ARBOR – C.S. Mott Children’s Hospital hosted an indoor parade through its cancer ward Tuesday in honor of National ...

The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...

Disparities continue in younger patients, raising the need for novel interventions to mitigate challenges associated with ...

Breast cancer diagnostics, therapeutics, and biomarker-driven therapy will be important focal points during the 22nd Annual ...

HANSIZHUANG (serplulimab) is the world's first anti-PD-1 mAb for first-line treatment of ES-  SCLC   - HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 ...

At the four-day-long event, representatives from pediatric cancer awareness foundations travel to Capitol Hill to speak to ...

Ann Arbor-based Michigan Medicine will establish the Weiser Family Center for Breast Cancer after receiving a $25 million gift from the Weiser Charitable Foundation.

The US Food and Drug Administration (FDA) has approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc ...

Data demonstrated statistically significant and clinically meaningful reduction in risk of disease progression or death with Cabometyx® ...

Naomi Dempsey, MD, discussed developments in the HER2-positive breast cancer space, including personalized approaches, less ...